Mattias Bergqvist

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Metastatic Breast Cancer

Tyrosine Kinase

Top Venues

Cancer research communications

Scandinavian journal of gastroenterology

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Ebba Asplund, Mattias Bergqvist, Maura Krook, Johannes Matthias Löhr
Plasma thymidine kinase activity as a prognostic biomarker in pancreatic ductal adenocarcinoma: a single-center prospective study. Scandinavian journal of gastroenterology (2023)
Jairam Krishnamurthy, Jingqin R Luo, Rama Suresh, Foluso O Ademuyiwa, Caron Rigden, Timothy Rearden, Katherine Clifton, Katherine Weilbaecher, Ashley Frith, Anna Roshal, Pavankumar K Tandra, Mathew Cherian, Tracy Summa, Brittney Haas, Shana Thomas, Leonel Hernandez-Aya, Mattias Bergqvist, Lindsey Peterson, Cynthia X Ma
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis. NPJ breast cancer 8 (1) (2022)
Costanza Paoletti, William E Barlow, Erin F Cobain, Mattias Bergqvist, Rita S Mehta, Julie R Gralow, Gabriel N Hortobagyi, Kathy S Albain, Lajos Pusztai, Priyanka Sharma, Andrew K Godwin, Alastair M Thompson, Daniel F Hayes, James M Rae
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)